Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DNL343, a brain-penetrating eIF2B (eukaryotic initiation factor 2B) activator, suppresses the abnormal integrated stress response (ISR). By inhibiting ISR activity in the central nervous system (CNS), DNL343 ameliorates neurodegeneration and neuroinflammation. Additionally, it protects against motor dysfunction and premature death in eIF2B loss-of-function (LOF) mutant mice and demonstrates inhibitory potential for vanishing white matter disease (VWMD) characterized by eIF2B LOF and persistent ISR activation [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 2,270.00 | |
50 mg | 6-8 weeks | $ 2,980.00 | |
100 mg | 6-8 weeks | $ 4,000.00 |
Description | DNL343, a brain-penetrating eIF2B (eukaryotic initiation factor 2B) activator, suppresses the abnormal integrated stress response (ISR). By inhibiting ISR activity in the central nervous system (CNS), DNL343 ameliorates neurodegeneration and neuroinflammation. Additionally, it protects against motor dysfunction and premature death in eIF2B loss-of-function (LOF) mutant mice and demonstrates inhibitory potential for vanishing white matter disease (VWMD) characterized by eIF2B LOF and persistent ISR activation [1]. |
Molecular Weight | 457.83 |
Formula | C20H19ClF3N3O4 |
CAS No. | 2278265-85-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
DNL343 2278265-85-1 inhibitor inhibit